Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Random DNA copying ‘mistakes’ account for most cancer mutations, study finds

Random DNA copying ‘mistakes’ account for most cancer mutations, study finds

Research suggests novel strategy to target genetic anomaly in prostate cancers

Research suggests novel strategy to target genetic anomaly in prostate cancers

New technology may provide non-invasive approach to diagnose and monitor prostate cancer

New technology may provide non-invasive approach to diagnose and monitor prostate cancer

Vanderbilt study compares side effects, outcomes of prostate cancer treatments with active surveillance

Vanderbilt study compares side effects, outcomes of prostate cancer treatments with active surveillance

Study sheds light on cellular mechanisms that enable prostate cancer cells to form secondary tumours

Study sheds light on cellular mechanisms that enable prostate cancer cells to form secondary tumours

Researchers discover new genes that help prevent prostate and other cancers

Researchers discover new genes that help prevent prostate and other cancers

Compressed course of radiation treatment benefits men with localized prostate cancer, study shows

Compressed course of radiation treatment benefits men with localized prostate cancer, study shows

Study uncovers genetic link to aggressive form of prostate cancer

Study uncovers genetic link to aggressive form of prostate cancer

Dietary anti-cancer compound from broccoli may work by influence on long non-coding RNAs

Dietary anti-cancer compound from broccoli may work by influence on long non-coding RNAs

Endostatin can decrease proliferation of castration-resistant prostate cancer cells

Endostatin can decrease proliferation of castration-resistant prostate cancer cells

Thyroid cancer patients opting for non-intervention face challenging path, study reveals

Thyroid cancer patients opting for non-intervention face challenging path, study reveals

Combination therapy that targets immune-busting cells effective in treating advanced prostate cancer

Combination therapy that targets immune-busting cells effective in treating advanced prostate cancer

TSRI researchers develop new drug candidates to target prostate and triple negative breast cancers

TSRI researchers develop new drug candidates to target prostate and triple negative breast cancers

Fraunhofer researchers develop method that enables focused ultrasound to treat liver tumors

Fraunhofer researchers develop method that enables focused ultrasound to treat liver tumors

Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

Drug could activate innate anti-tumor immunity to eradicate aggressive prostate cancer in mice

Study offers new insights into biological causes of premature baldness in men

Study offers new insights into biological causes of premature baldness in men

Michigan Medicine opens first clinic in the United States that focuses on prostate cancer risk

Michigan Medicine opens first clinic in the United States that focuses on prostate cancer risk

Rheumatoid arthritis drug blocks metabolic pathway, reduces breast cancer tumors in mice

Rheumatoid arthritis drug blocks metabolic pathway, reduces breast cancer tumors in mice

Study provides insights into how cancer cells can evade FGFR inhibitors

Study provides insights into how cancer cells can evade FGFR inhibitors

Study highlights potential tolerability of single fraction of HDR brachytherapy for localized prostate cancer

Study highlights potential tolerability of single fraction of HDR brachytherapy for localized prostate cancer